Latest Congressional polls: Lee Carter on CNN
Do Americans care about the latest Congressional polls? Lee Carter chimes in on CNN about what really matters today.| maslansky+partners
There are moments in American politics when the ground shifts beneath our feet; when something that seemed fringe, even laughable, suddenly becomes the center of gravity. Today, that something is the MAHA movement: "Make America Healthy Again." According to Lee Carter in this opinion piece for FoxNews.com, dismissing MAHA is not just shortsighted, it’s dangerous. The post Lee Carter on the MAHA Initiative: Opinion piece on Foxnews.com appeared first on maslansky+partners.| maslansky+partners
What's in a name? Everything, if you consider the Trump administration's decision to rechristen the Department of Defense to the Department of War. Lee Carter chimes in on the debate in this provocative thought piece. The post Lee Carter on “The Dept of War”: Opinion piece on Foxnews.com appeared first on maslansky+partners.| maslansky+partners
Do Americans care about the latest Congressional polls? Lee Carter chimes in on CNN about what really matters today.| maslansky+partners
Lee Carter shares four key steps pharma companies can take to engage more productively with the MAHA movement.| maslansky+partners
When it comes to corporate storytelling, companies can use the Goldilocks Principle to find the communication approach that's "just right."| maslansky+partners
In responding to the executive order on drug pricing, pharma companies have a chance to redefine their narrative.| maslansky+partners
People are angry. From DEI to tariffs and rising prices, companies need to understand how to respond & communicate in this new "age of rage."| maslansky+partners
Here are five corporate communication strategies that won't work in this evolving environment, and a guide on how to communicate successfully.| maslansky+partners
Five steps companies can take that will allow them to continue to work towards their DEI goals while mitigating the risk.| maslansky+partners
In this episode, we dissect the challenges of selling innovation whether you are selling enterprise technology, a new investment product, or plant-based meat.| maslansky+partners
